TPO and autoimmune thrombocytopenic purpura: Recent studies have highlighted the ability of ELTRO to reverse the macrophage (M1)-associated characteristics of ITP [30], and TPO-RAs have been shown to have additional immunomodulatory activity, including the restoration of monocyte dynamics and the balancing of T-helper cell types [30].